Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
2064 J . Org. Chem., Vol. 66, No. 6, 2001
Nevalainen et al.
Visualization was accomplished with UV light, iodine or 1%
KMnO4 in H2O. Flash chromatography was performed using
Merck silica gel 60 (40-63 µm). The detector wavelength, flow
rate and solvents were as denoted. The retention times (tR)
for the enantiomers are reported.
2 L three-necked round-bottomed flask were placed Raney Ni
(13.0 g, 50% w/w slurry in water, 50 mol %) and [2E,3(4S)]-
2-methyl-3-[N-[(1,1-dimethyl)ethoxycarbonyl]-2,2-dimethyl-
1,3-oxazolidin-4-yl]propenyl alcohol (13.0 g, 46.8 mmol) in
MeOH (1300 mL). The flask was filled with hydrogen, the
mixture was stirred at room temperature for 18 h and filtered
through a pad of Celite, and the solvent was eliminated under
reduced pressure. The residue was taken up in Et2O (100 mL)
and washed with H2O (2 × 50 mL). The organic layer was dried
(MgSO4) and filtered and the solvent removed under reduced
pressure. 5 was obtained as a clear oil (12.1 g, 44.4 mmol, 95%)
Solvents were dried using standard procedures.16 D-Serine
was purchased from Fluka. DIBAL-H (1 M in toluene) was
obtained from Aldrich and KHMDS (0.5 M in toluene) was
obtained from Fluka. 10% Pt/C, Pt2O, and Raney Nickel (50%
w/w slurry in H2O, pH ) 10) were purchased from Aldrich,
and 5% Ir/C from Alfa. Garner’s aldehyde7,17 and phosphorane
218 were synthesized as described in the literature.
with dr ) 86:14 (two rotamers): [R]20 +32.6 (c 0.98, CHCl3)
D
[2E,3(4S)]-2-Met h yl-3-[N-[(1,1-d im et h yl)et h oxyca r bo-
for dr ) 70:30; [R]20 ) +34.5 (c 1.06, CHCl3) for dr ) 86:14;
D
n yl]-2,2-d im et h yl-1,3-oxa zolid in -4-yl]p r op en oic
Acid
1H NMR (400 MHz, CDCl3) δ 4.20-4.00 (bs, 1H), 4.00-3.80
(m, 1H), 3.80-3.64 (m, 1H), 3.60-3.38 (bs, 2H), 3.24-3.00 (bs,
1H), 1.80-1.66 (m, 2H), 1.66-1.50 (m, 4H), 1.50-1.34 (m,
12H), 1.02-0.86 (m, 3H); 13C NMR (100 MHz, CDCl3) δ 152.6,
152.4, 161.6, 93.6, 93.2, 93.1, 80.4, 79.5, 68.5, 68.2 67.9, 67.6,
67.2, 67.0, 55.8 (minor diastereoisomer), 55.6 and 55.1 (major
diastereoisomer), 38.1 (minor diastereoisomer), 37.4 and 37.1
(major diastereoisomer), 33.6, 33.0, 32.9, 28.5, 28.4, 27.7, 26.6,
26.9, 24.5, 24.4, 23.2, 18.4 and 18.1 (minor diastereoisomer),
16.5 and 16.0 (major diastereoisomer); HRMS calcd for M+
(C14H27NO4) 273.1933, found 273.1938.
Meth yl Ester (3). In a 1 L three-necked round-bottomed flask
was placed under argon (R-carbomethoxyethylidene)triphenyl-
phosphorane (38.6 g, 110 mmol, 110 mol %) in dry CH2Cl2 (500
mL). The solution was cooled to 0 °C, and (4R)-4-formyl-2,2-
dimethyloxazolidine-3-carboxylic acid tert-butyl ester (22.9 g,
100 mmol) in dry CH2Cl2 (200 mL) was dropwise added. The
ice/water bath was removed, and the mixture was stirred at
room temperature for 18 h. The solution was concentrated
under reduced pressure. The residue (150 mL) was treated
with hexane (500 mL), cooled to 0 °C, and stirred at that
temperature for 30 min. The solid was filtered washed with
hexane (2 × 100 mL). The solvent was evaporated from the
filtrate at reduced pressure, and the residue was purified by
flash chromatography (silica, Hex/AcOEt 5:1). A clear oil was
[2R,3(4S)]-1-Ch lor o-2-m eth yl-3-[N-[(1,1-dim eth yl)eth oxy-
ca r bon yl]-2,2-d im eth yl-1,3-oxa zolid in -4-yl]p r op a n e (6a ).
In a 1 L three-necked round-bottomed flask under argon was
placed [2R,3(4S)]-2-methyl-3-[N-[(1,1-dimethyl)ethoxycarbo-
nyl]-2,2-dimethyl-1,3-oxazolidin-4-yl]propanol (12.0 g, 44.2
mmol) of dr ) 86:14 in acetonitrile (650 mL). K2CO3 (12.3 g,
89.7 mmol, 200 mol %), Ph3P (29.6 g, 164.9 mmol, 250 mol %),
and CCl4 (43 mL) were added. The mixture was stirred at room
temperature for 1 h and the solvent evaporated under reduced
pressure. The residue was purified by flash chromatography
(silica, Hex/AcOEt 4:1 and 2:1). Two fractions were obtained:
the target molecule (6a ) as an oil (1.8 g, 6.0 mmol, 14%), and
the hemiaminal cleaved product (7a ) also as an oil (5.4 g, 21.4
mmol, 48%). 6a (two rotamers): [R]20D +22.5 (c ) 1.13, CHCl3);
1H NMR (400 MHz, CDCl3, 45 °C) δ 4.15-3.77 (bs, 1H), 3.91
(m, 1H), 3.70 (d, J ) 8.8 Hz, 1H), 3.44 (bs, 2H), 1.85-1.60 (bs,
3H), 1.55 (m, 3H), 1.46-1.40 (m, 12H), 1.04 (bs, 3H); 13C NMR
(100 MHz, CDCl3) δ 152.1, 151.5, 93.7, 93.2, 80.0, 79.7, 66.9,
66.8, 55.5, 55.5, 51.3, 51.2, 38.0, 37.3, 33.4, 28.4, 27.7 (rotamer),
26.9, 24.5 (rotamer), 23.2, 17.4, 17.1; HRMS calcd for M+
(C14H26NO3Cl) 291.1575, found 291.1578.
obtained (21.5 g, 71.9 mmol, 72%): Rf ) 0.41 (silica, Hex/
1
AcOEt 5:2); [R]20 +19.3 (c 0.55, CHCl3); H NMR (400 MHz,
D
CDCl3) δ 6.66 (bs, 1H), 4.78-4.59 (bs, 1H), 4.12 (dd, J ) 8.8
Hz, J ) 6.4 Hz, 1H), 3.76 (s, 3H), 3.71 (dd, J ) 8.8, 3.0 Hz,
1H), 1.91 (m, 3H), 1.63 (m, 3H), 1.55-1.40 (m, 12H); 13C NMR
(100 MHz, CDCl3) δ 168.1, 152.0 (rotamer), 151.7, 140.9, 140.6
(rotamer), 128.8 (rotamer), 127.8, 94.4, 93.8 (rotamer), 80.4
(rotamer), 80.0, 67.6, 55.3, 51.8, 28.3, 27.2 (rotamer), 26.2, 25.0
(rotamer), 24.1, 12.5; HRMS calcd for M+ (C15H25NO5) 299.1726,
found 299.1733.
[2E,3(4S)]-2-Met h yl-3-[N-[(1,1-d im et h yl)et h oxyca r bo-
n yl]-2,2-d im et h yl-1,3-oxa zolid in -4-yl]p r op en yl Alcoh ol
(4). In a 250 mL two-necked round-bottomed flask under argon
was placed DIBAL-H (1 M in toluene, 90 mL, 90 mmol, 180
mol %) and the mixture cooled to -50 °C. A solution of [2E,3-
(4S)]-2-methyl-3-[N-[(1,1-dimethyl)ethoxycarbonyl]-2,2-dimethyl-
1,3-oxazolidin-4-yl]propenoic acid methyl ester (15.0 g, 50.3
mmol) in dry toluene (15 mL) was dropwise added. The
mixture was stirred at -50 °C for 5 h, quenched with acetone
(60 mL), and allowed to warm to room temperature by removal
of the dry ice/CHCl3 bath. When the mixture started to jellify,
it was poured into a solution of sodium potassium tartrate (113
g) in H2O (300 mL), with the aid of Et2O (2 × 10 mL). The
biphasic mixture was stirred vigorously at room temperature
for 1 h, the layers were separated, and the aqueous layer was
extracted with Et2O (3 × 100 mL). The combined organic
extracts were dried (MgSO4) and filtered, and the solvent was
evaporated under reduced pressure. The crude product was
purified by flash chromatography (silica, Hex/AcOEt 3:1). A
clear oil was obtained (12.0 g, 44.2 mmol, 88%): Rf ) 0.34
[2R,3(4S)]-1-Br om o-2-m eth yl-3-[N-[(1,1-dim eth yl)eth oxy-
ca r bon yl]-2,2-d im eth yl-1,3-oxa zolid in -4-yl]p r op a n e (6b).
In a 25 mL two-necked round-bottomed flask under argon was
placed [2R,3(4S)]-2-methyl-3-[N-[(1,1-dimethyl)ethoxycarbo-
nyl]-2,2-dimethyl-1,3-oxazolidin-4-yl]propanol (280 mg, 1.03
mmol) of dr ) 80:20 in dry THF (10 mL). Ph3P (538 mg, 2.06
mmol, 200 mol %) and CBr4 (682 mg, 2.06 mmol, 200 mol %)
were added, followed by (iPr)2EtNH (359 µL, 2.06 mmol, 200
mol %). The mixture was stirred at room temperature for 1 h,
diluted with Et2O (75 mL), and extracted with 0.5 N H3PO4 (2
× 25 mL), saturated Na2CO3 (25 mL), and brine (25 mL). The
acidic and neutral extracts were washed with Et2O (2 × 25
mL), the combined organic extracts were dried (MgSO4) and
filtered, and the solvent was evaporated under reduced pres-
sure. The residue was treated with Hex/AcOEt 4:1 (10 mL),
cooled to 0 °C, and filtered. The solid was washed with Hex/
AcOEt 4:1 (5 mL), and the combined filtrates were evaporated
to dryness under reduced pressure. The residue was filtered
through a short pad of silica with the aid of Hex/AcOEt 4:1
(50 mL). The target molecule was obtained as an oil (310 mg,
(silica, Hex/AcOEt 1:1); [R]20 -16.5 (c 0.61, CHCl3); 1H NMR
D
(400 MHz, CDCl3) δ 5.46, 5.27 (d, J ) 9.2 Hz, 1H), 4.72-4.52
(bs, 1H), 4.07 (dd, J ) 8.8, 6.4 Hz, 1H), 4.02 (s, 2H), 3.66 (dd,
J ) 8.8, 3.2 Hz, 1H), 1.80-1.34 (m, 19H); 13C NMR (100 MHz,
CDCl3) δ 152.1, 137.1, 135.9 (rotamer), 125.5 (rotamer), 125.2,
93.9, 80.1, 68.6, 68.0, 55.1, 28.5, 27.1 (rotamer), 26.4, 25.2
(rotamer), 24.0, 13.8; HRMS calcd for M+ (C14H25NO4) 271.1777,
found 271.1709.
0.92 mmol, 90%) (two rotamers): [R]20 ) -14.2 (c ) 0.62,
D
CHCl3); 1H NMR (400 MHz, CDCl3) δ 4.06-3.80 (bs, 1H), 3.92
(m, 1H), 3.73 (dd, J ) 8.8 Hz, J ) 1.2 Hz, 1H), 3.52-3.24 (bs,
2H), 2.00-1.60 (bs, 3H), 1.60-1.50 (m, 3H), 1.50-1.40 (m,
12H), 1.08 (bs, 3H); 13C NMR (100 MHz, CDCl3) δ 152.2, 151.5,
93.7, 93.3, 80.1, 79.7, 66.9, 65.7, 55.5, 55.5, 50.1, 41.4, 40.9,
39.4, 38.9, 38.3, 36.8, 36.5, 33.0, 31.6, 28.5, 28.4, 28.3, 27.8
(rotamer), 26.9, 24.5 (rotamer), 23.2, 20.1, 19.8, 18.5, 18.2;
HRMS calcd for M+ - 71 (C10H19NO2Br) 264.0595, found
264.0566.
[2R,3(4S)]-2-Meth yl-3-[N-[(1,1-d im eth yl)eth oxyca r bo-
n yl]-2,2-d im eth yl-1,3-oxa zolid in -4-yl]p r op a n ol (5b). In a
(16) Furniss, B. S.; Hannaford, A. J .; Smith, P. W. G.; Tatchell, A.
R. Vogel’s Textbook of Practical Organic Chemistry, 5th ed.; Long-
man: Harlow, U.K., 1989.
(17) Williams, L.; Zhang, Z.; Shao, F.; Carroll, P. J .; J oullie´, M. M.
Tetrahedron 1996, 52, 11673-11694.
(18) Isler, O. Von; Gutmann, H.; Montavon, M.; Ru¨egg, R.; Ryser,
G.; Zeller, P. Helv. Chim. Acta 1957, 139, 1242-1249.